VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
GMED
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
GMEDGlobus Medical, Inc.
$83.94$11.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksGMEDQuarterly Financials

Globus Medical, Inc. (GMED) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Globus Medical, Inc. (GMED) quarterly income statement — complete revenue, gross profit & net income history

GMED Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Sales/Revenue759.85M826.39M769.05M745.34M598.12M657.29M625.71M629.69M606.67M616.53M383.64M291.62M
Revenue Growth %27.04%25.73%22.91%18.37%-1.41%6.61%63.1%115.93%119.26%124.6%50.95%10.61%
Cost of Goods Sold234.07M231.26M282.38M248.76M195.4M263.44M270.51M260.04M241.49M265.49M135.39M76.47M
COGS % of Revenue30.8%27.98%36.72%33.38%32.67%40.08%43.23%41.3%39.81%43.06%35.29%26.22%
Gross Profit525.79M595.13M486.67M496.58M402.72M393.86M355.19M369.65M365.18M351.05M248.25M215.14M
Gross Margin %69.2%72.02%63.28%66.62%67.33%59.92%56.77%58.7%60.19%56.94%64.71%73.78%
Gross Profit Growth %30.56%51.1%37.02%34.34%10.28%12.19%43.08%71.82%77.39%72.16%31.59%10.23%
Operating Expenses363.81M423.45M351.66M420.47M305.72M333.58M307.09M320.03M357.18M340.93M247.84M148.93M
OpEx % of Revenue47.88%51.24%45.73%56.41%51.11%50.75%49.08%50.82%58.88%55.3%64.6%51.07%
Selling, General & Admin297.77M456.28M313.6M303.62M242.8M253.48M240.74M239.45M248.68M244.72M156.21M120.07M
SG&A % of Revenue39.19%55.21%40.78%40.74%40.59%38.56%38.47%38.03%40.99%39.69%40.72%41.17%
Research & Development36.51M73.92M38.07M39.95M33.06M33.41M35.38M37.7M57.27M52.25M29.33M21.35M
R&D % of Revenue4.8%8.94%4.95%5.36%5.53%5.08%5.65%5.99%9.44%8.48%7.64%7.32%
Other Operating Expenses1000K-1000K01000K1000K1000K1000K1000K1000K1000K1000K1000K
Operating Income163.57M171.68M135.01M76.11M97M60.27M48.1M49.62M8M10.12M404K66.21M
Operating Margin %21.53%20.77%17.56%10.21%16.22%9.17%7.69%7.88%1.32%1.64%0.11%22.71%
Operating Income Growth %68.62%184.83%180.69%53.38%1113%495.42%11805.45%-25.06%-85.82%-81.26%-99.32%-2.31%
EBITDA233.43M242.01M206.13M146.74M163.08M128.5M115.05M113.21M63.26M81.28M37.79M84.29M
EBITDA Margin %30.72%29.28%26.8%19.69%27.27%19.55%18.39%17.98%10.43%13.18%9.85%28.9%
EBITDA Growth %43.14%88.33%79.18%29.62%157.8%58.09%204.42%34.31%-15.1%14.59%-51.1%-0.49%
D&A (Non-Cash Add-back)69.86M70.33M71.13M70.63M66.07M68.23M66.95M63.59M55.26M71.16M37.39M18.07M
EBIT163.57M174.06M143.99M122.81M98.06M77.06M49M62.79M29.56M25.95M48.95M69.18M
Net Interest Income5.43M3.31M1.46M693K1.68M-815K-775K-2.33M-1.89M-2.58M7.92M-8.29M
Interest Income5.43M3.31M1.46M693K1.68M000007.92M0
Interest Expense00000815K775K2.33M1.89M2.58M08.29M
Other Income/Expense-6.5M2.39M8.99M112.06M6.66M-35.61M8.93M-2.04M-16.55M14.87M2.13M8.46M
Pretax Income157.07M174.06M143.99M188.17M103.67M24.67M57.03M47.58M-8.56M24.99M2.54M74.67M
Pretax Margin %20.67%21.06%18.72%25.25%17.33%3.75%9.11%7.56%-1.41%4.05%0.66%25.61%
Income Tax32.77M33.44M25.03M-14.67M28.21M-1.84M5.2M15.82M-1.44M9.96M1.54M16.96M
Effective Tax Rate %20.86%19.21%17.38%-7.8%27.21%-7.45%9.11%33.25%16.84%39.85%60.63%22.71%
Net Income124.3M140.63M118.97M202.85M75.46M26.5M51.84M31.76M-7.12M15.03M998K57.71M
Net Margin %16.36%17.02%15.47%27.22%12.62%4.03%8.28%5.04%-1.17%2.44%0.26%19.79%
Net Income Growth %64.72%430.56%129.5%538.68%1160.31%76.3%5093.99%-44.97%-114.49%-69.97%-97.9%5.72%
Net Income (Continuing)124.3M140.63M118.97M202.85M75.46M26.5M51.84M31.76M-7.12M15.03M998K57.71M
Discontinued Operations000000000000
Minority Interest000000000000
EPS (Diluted)0.901.010.881.490.540.190.380.23-0.050.110.010.57
EPS Growth %66.67%431.58%131.58%547.83%1126.62%72.73%--59.65%-110.96%-77.55%-98.15%7.55%
EPS (Basic)0.921.050.881.500.550.190.380.23-0.050.110.010.57
Diluted Shares Outstanding138.19M137.22M135.39M136.5M139.77M139.71M138.06M136.98M135.36M139.02M115.25M101.78M
Basic Shares Outstanding135.36M135.15M134.5M135.21M136.76M136.73M135.62M135.19M135.36M137.88M113.54M100.37M
Dividend Payout Ratio------------